The introduction:

Lumbrokinase has been proved to have a good clinical application value, it is a kind of many molecular recombination oral preparation, and thromboembolism (fiber protein) have a special affinity, able to track thrombolysis, effectively dissolve micro bolt, improve microcirculation, strengthen the heart, cerebrovascular collateral circulation, openness to repair damaged vascular endothelial cells, increase vascular elasticity, improve vascular oxygen function, reduce the blood viscosity, reduce platelet aggregation rate, restrain thrombosis formation again. Repair thrombosis after the occurrence of a peripheral necrotic brain cells, save half dark space. Has been widely used in clinical, and more and more with heart, cerebrovascular, endocrine, respiratory system disease prevention and treatment center.

The Drug Development prospect:

The current clinical trials show that hemangioblastomas kinase to coronary heart disease, angina cerebral infarction diabetic nephropathy syndrome cor pulmonale and lower extremity deep venous thrombosis is a common, such as treatment function exactly, and bad reflect small, patients easy tolerance although there are many problems need to be large-scale, long time clinical controlled study and resolve, but looking to the future, rearing kinase in clinical disease in the application will have a better prospects.

Helpful for some disease:

1.Can cure coronary disease

2.Can cure the cerebral infarction

3.Can cure the Diabete

4.Can cure the nephrotic syndrome

5.Can cure the curepulmonary heart disease

6.Can cure the deep venous thrombosis